Catalent Inc (NASDAQ:CTLT) Rating Increased to Buy at BidaskClub

Catalent Inc (NASDAQ:CTLT) was upgraded by BidaskClub from a “hold” rating to a “buy” rating in a research note issued on Thursday, October 5th.

A number of other research firms have also weighed in on CTLT. Zacks Investment Research raised shares of Catalent from a “hold” rating to a “buy” rating and set a $39.00 target price on the stock in a research note on Tuesday, August 22nd. William Blair reissued an “ourperform” rating on shares of Catalent in a research note on Tuesday, August 29th. ValuEngine raised shares of Catalent from a “hold” rating to a “buy” rating in a research note on Thursday, September 7th. Bank of America Corporation restated a “buy” rating and set a $38.00 price target (up previously from $37.00) on shares of Catalent in a report on Friday, July 21st. Finally, J P Morgan Chase & Co restated a “buy” rating and set a $40.00 price target on shares of Catalent in a report on Tuesday, August 29th. Five analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $38.64.

Catalent (NASDAQ CTLT) opened at 41.55 on Thursday. The company has a market capitalization of $5.20 billion and a price-to-earnings ratio of 47.76. The stock’s 50 day moving average price is $40.64 and its 200 day moving average price is $35.37. Catalent has a 12 month low of $21.83 and a 12 month high of $42.96.

Catalent (NASDAQ:CTLT) last released its earnings results on Monday, August 28th. The company reported $0.65 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.57 by $0.08. Catalent had a net margin of 10.02% and a return on equity of 36.29%. The business had revenue of $616.90 million for the quarter, compared to analyst estimates of $547.48 million. During the same period last year, the company posted $0.52 EPS. The business’s revenue was up 15.9% on a year-over-year basis. Equities research analysts anticipate that Catalent will post $1.62 earnings per share for the current fiscal year.

WARNING: “Catalent Inc (NASDAQ:CTLT) Rating Increased to Buy at BidaskClub” was first published by BBNS and is the property of of BBNS. If you are viewing this piece on another publication, it was copied illegally and reposted in violation of U.S. and international trademark & copyright legislation. The original version of this piece can be read at https://baseballnewssource.com/markets/bidaskclub-upgrades-catalent-inc-ctlt-to-buy/1700456.html.

In other Catalent news, SVP Christine Dolan sold 745 shares of the firm’s stock in a transaction that occurred on Tuesday, August 1st. The shares were sold at an average price of $34.85, for a total value of $25,963.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Institutional investors have recently added to or reduced their stakes in the company. Acrospire Investment Management LLC lifted its position in Catalent by 72.2% in the second quarter. Acrospire Investment Management LLC now owns 3,100 shares of the company’s stock valued at $109,000 after acquiring an additional 1,300 shares during the last quarter. Quantbot Technologies LP lifted its position in Catalent by 110.7% in the second quarter. Quantbot Technologies LP now owns 3,434 shares of the company’s stock valued at $120,000 after acquiring an additional 1,804 shares during the last quarter. PNC Financial Services Group Inc. lifted its position in Catalent by 66.5% in the first quarter. PNC Financial Services Group Inc. now owns 6,070 shares of the company’s stock valued at $173,000 after acquiring an additional 2,425 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Catalent by 12.5% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,043 shares of the company’s stock valued at $177,000 after acquiring an additional 559 shares during the last quarter. Finally, Advisor Group Inc. lifted its position in Catalent by 1.3% in the second quarter. Advisor Group Inc. now owns 5,185 shares of the company’s stock valued at $180,000 after acquiring an additional 65 shares during the last quarter.

About Catalent

Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.

Analyst Recommendations for Catalent (NASDAQ:CTLT)

Receive News & Ratings for Catalent Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent Inc and related companies with our FREE daily email newsletter.

 


Latest News

Houston’s Dallas Keuchel Could Make Relief Appearance in Game 7
Houston’s Dallas Keuchel Could Make Relief Appearance in Game 7
Houston Astros Relying on Justin Verlander to Save Their Season
Houston Astros Relying on Justin Verlander to Save Their Season
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Aaron Judge and Gary Sanchez Have Break Out Games
Aaron Judge and Gary Sanchez Have Break Out Games
Justin Turner Joining Postseason Legends
Justin Turner Joining Postseason Legends
PED Use Cost Alex Rodriguez Millions and His Reputation
PED Use Cost Alex Rodriguez Millions and His Reputation


Leave a Reply

 
© 2006-2017 BBNS.